vicc
Wilson awarded Komen breast cancer research grant
Sep. 25, 2019—An engineering professor has received financial support from Susan G. Komen for breast cancer research. His project is among 60 grants totaling $26 million awarded to researchers nationwide. Those initiatives are focused on improving outcomes for metastatic breast cancer, reducing disparities in survivorship and developing new, more effective treatments. John T. Wilson, assistant professor of...
Investigators map genomic landscape of very rare cancer
Feb. 28, 2019—A team of Vanderbilt researchers mapped out the genomic landscape of a metastatic malignant proliferating tricholemmal tumor and identified a targeted treatment for this very rare cancer.
Discovery of new “checkpoint” points to new cancer immunotherapy option
Feb. 21, 2019—An international team involving Vanderbilt researchers has discovered that a new “checkpoint” protein on immune system cells is active in tumors, and that blocking it — in combination with other treatments — is a successful therapeutic approach in mouse models of cancer.
Research explores link between stem cell transplant, diabetes
Jan. 17, 2019—Brian Engelhardt is studying why as many as 50 percent of stem cell transplant recipients develop diabetes.
VICC experts to discuss high risk breast cancer at free seminar June 6
May. 26, 2017—Vanderbilt-Ingram Cancer Center (VICC), in collaboration with the Hereditary Cancer Program and the Vanderbilt Breast Center, is hosting a free seminar, “Are You at High Risk for Breast Cancer?”
VICC Annual Scientific Retreat slated for May 4
Apr. 20, 2017—Leading cancer investigators from several prominent universities and laboratories will headline the 2017 Vanderbilt-Ingram Cancer Center (VICC) Annual Scientific Retreat May 4.
Annual Meharry–Vanderbilt–TSU Cancer Partnership retreat April 8
Mar. 23, 2017—The Meharry Medical College, Vanderbilt-Ingram Cancer Center (VICC) and Tennessee State University (TSU) Cancer Partnership will host its 16th Annual Cancer Retreat on April 8.
Know the facts about ovarian cancer
Sep. 16, 2016—Listening to the body and being aware of individual risks are especially important when it comes to ovarian cancer. Vanderbilt–Ingram Cancer Center provides the facts.
VICC joins other major cancer centers in HPV vaccine campaign
Feb. 4, 2016—In response to low national vaccination rates for the human papillomavirus (HPV), Vanderbilt-Ingram Cancer Center (VICC) has joined 68 of the nation’s other NCI-designated cancer centers in recommending increased HPV vaccination for the prevention of cancer.
VICC annual retreat slated for April 30
Apr. 9, 2015—Vanderbilt-Ingram Cancer Center’s annual retreat will be held Thursday, April 30, 8 a.m.—3 p.m. at the Vanderbilt Student Life Center.
VUMC oncology programs recognized
Aug. 7, 2014—Becker’s Hospital Review has named Vanderbilt University Medical Center among the “100 Hospitals and Health Systems With Great Oncology Programs.”
Moses to receive Vanderbilt Distinguished Alumni Award
Jan. 20, 2014—Harold “Hal” Moses, the Hortense B. the Ingram Professor of Cancer Research at Vanderbilt University, is the recipient of the 2014 Distinguished Alumni Award — the highest honor for a member of the Vanderbilt alumni community.